-+ 0.00%
-+ 0.00%
-+ 0.00%

FULCRUM THERAPEUTICS ANNOUNCES POSITIVE INITIAL RESULTS FROM THE 20 MG DOSE COHORT OF THE PHASE 1B PIONEER TRIAL OF POCIREDIR IN SICKLE CELL DISEASE AT THE 67TH AMERICAN SOCIETY OF HEMATOLOGY ANNUAL MEETING

Reuters·12/06/2025 22:30:02

Please log in to view news